Stay updated with breaking news from Human Abuse Potential. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral...
Ensysce Biosciences Reports First Quarter 2023 Financial Results
~ Corporate Update Call to be Held Tuesday, April 11, 2023 ~SAN DIEGO, CA / ACCESSWIRE / March 30, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage biotech
Ensysce Biosciences Reports Fourth Quarter and Full Year 2022 Financial ...
Company Remains on Track to Report Results the End of MarchSAN DIEGO, CA / ACCESSWIRE / February 28, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage biotech